Johnson & Johnson Family of Companies
NEWS
Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?
The Life Science Women’s Conference is being held on February 19 and 20 at the Tampa Bay Convention Center in Tampa, Florida. Co-founded by Patti Rossman and Steve Fiske, the conference is an opportunity for women to accelerate their life science careers via mentoring, networking and education.
The World Health Organization (WHO) gave the coronavirus that began in Wuhan, China, an official name, COVID-19.
The biotech Hotbed known as Pharm Country, which includes New Jersey, Connecticut, New York Pennsylvania and Rhode Island, is an area of rapid growth and change.
Consulting firm EY released its annual report on mergers and acquisitions (M&A) to coincide with the JP Morgan Healthcare conference this week. For 2019, EY indicates there were $357 billion in life science deals, an “all-time record,” surpassing the previous high in 2014.
The start of 2020 has also brought the need for some companies in the pharma industry to acquire the next size up in building space as they expand their employee headcount.
Amunix Pharmaceuticals, based in Mountain View, California, entered a licensing deal with Roche. Under the terms of the deal, Roche will pay Amunix $40 million upfront.
FARE said the biomarker research project, which will be conducted at Janssen’s World Without Disease Accelerator, “has the potential to make a real and significant impact for the 32 million Americans living with food allergies.”
The year was marked by mergers and acquisitions both big and small. Although not comprehensive, here’s a look at some of the top deals for 2019.
JOBS
IN THE PRESS